Introduction to ART (November 2024)

4 December 2024. Related: Guides, Publications.

This widely used guide to HIV treatment (ART) has been updated online.

Unfortunately, this is the first year since 2000 when we have not been able to fund a printed version.

All online pages have been updated and edited.

Changes in the 2024 edition include:

New information is included for transgender and non-binary people and ART.
Information is included about choice of ART and current guidelines. This includes that guidelines recommend integrase inhibitors – either dolutegravir or bictegravir – for first-line ART.
The section on choice of first-line ART has been updated to focus on the most commonly used combinations.
The guide includes new information about weight changes as a side effect of some HIV drugs.
It also includes recent options for two-drug ART with some drugs. This includes cabotegravir/rilpivirine long-acting injections – but only as a switch option. These injections are now available in the UK. This is only for some people.
The section on future drugs has been updated.
The guide and 4-page drug chart in the centre pages have been updated to include new drugs and formulations. Pill sizes approximate to actual size.